State of the art in osteoporosis risk assessment and treatment

<p><strong>Background</strong> Osteoporosis constitutes a major public health problem, through its association with age-related fractures, particularly of the hip, vertebrae, distal forearm, and humerus. Over recent decades, it has evolved from being viewed as an inevitable consequ...

Full description

Bibliographic Details
Main Authors: Liu, J, Curtis, E, Cooper, C, Harvey, N
Format: Journal article
Language:English
Published: Elsevier 2019
_version_ 1797061427491504128
author Liu, J
Curtis, E
Cooper, C
Harvey, N
author_facet Liu, J
Curtis, E
Cooper, C
Harvey, N
author_sort Liu, J
collection OXFORD
description <p><strong>Background</strong> Osteoporosis constitutes a major public health problem, through its association with age-related fractures, particularly of the hip, vertebrae, distal forearm, and humerus. Over recent decades, it has evolved from being viewed as an inevitable consequence of ageing, to being recognised as a serious and eminently treatable disease.</p> <p><strong>Materials and methods</strong> In this article, we review the literature pertaining to the epidemiology of osteoporosis, associated health burden, approaches to risk assessment and treatment.</p> <p><strong>Results</strong> Although there is some evidence that fracture incidence has reached a plateau, or even started to decline, in the developed world, an ageing population and adoption of westernised lifestyles in transitioning populations is leading to an increasing burden of osteoporosis across the world. Whilst the clinical definition of osteoporosis has been based solely on bone mineral density, the prediction of fracture at the individual level has been improved by consideration of clinical risk factors in tools such as FRAX<sup>®</sup>, derived from a greater understanding of the epidemiology of osteoporosis. Such advances in approaches to primary and secondary prevention of fractures, coupled with elucidation of the underlying biology, and the development of a range of highly effective antiosteoporosis medications, have enabled a step change in our ability to prevent osteoporosis-related fractures. However, there remains a substantial disparity between the number of individuals at high fracture risk and number treated globally.</p> <p><strong>Conclusion</strong> Urgent work is needed at the level of health care systems, national and international policy, and in communication with patients and public, to ensure that all patients who should receive treatment for osteoporosis actually do so.</p>
first_indexed 2024-03-06T20:31:00Z
format Journal article
id oxford-uuid:31076255-cf86-4eaf-bd26-c2c7810f84e9
institution University of Oxford
language English
last_indexed 2024-03-06T20:31:00Z
publishDate 2019
publisher Elsevier
record_format dspace
spelling oxford-uuid:31076255-cf86-4eaf-bd26-c2c7810f84e92022-03-26T13:05:21ZState of the art in osteoporosis risk assessment and treatmentJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:31076255-cf86-4eaf-bd26-c2c7810f84e9EnglishSymplectic Elements at OxfordElsevier2019Liu, JCurtis, ECooper, CHarvey, N<p><strong>Background</strong> Osteoporosis constitutes a major public health problem, through its association with age-related fractures, particularly of the hip, vertebrae, distal forearm, and humerus. Over recent decades, it has evolved from being viewed as an inevitable consequence of ageing, to being recognised as a serious and eminently treatable disease.</p> <p><strong>Materials and methods</strong> In this article, we review the literature pertaining to the epidemiology of osteoporosis, associated health burden, approaches to risk assessment and treatment.</p> <p><strong>Results</strong> Although there is some evidence that fracture incidence has reached a plateau, or even started to decline, in the developed world, an ageing population and adoption of westernised lifestyles in transitioning populations is leading to an increasing burden of osteoporosis across the world. Whilst the clinical definition of osteoporosis has been based solely on bone mineral density, the prediction of fracture at the individual level has been improved by consideration of clinical risk factors in tools such as FRAX<sup>®</sup>, derived from a greater understanding of the epidemiology of osteoporosis. Such advances in approaches to primary and secondary prevention of fractures, coupled with elucidation of the underlying biology, and the development of a range of highly effective antiosteoporosis medications, have enabled a step change in our ability to prevent osteoporosis-related fractures. However, there remains a substantial disparity between the number of individuals at high fracture risk and number treated globally.</p> <p><strong>Conclusion</strong> Urgent work is needed at the level of health care systems, national and international policy, and in communication with patients and public, to ensure that all patients who should receive treatment for osteoporosis actually do so.</p>
spellingShingle Liu, J
Curtis, E
Cooper, C
Harvey, N
State of the art in osteoporosis risk assessment and treatment
title State of the art in osteoporosis risk assessment and treatment
title_full State of the art in osteoporosis risk assessment and treatment
title_fullStr State of the art in osteoporosis risk assessment and treatment
title_full_unstemmed State of the art in osteoporosis risk assessment and treatment
title_short State of the art in osteoporosis risk assessment and treatment
title_sort state of the art in osteoporosis risk assessment and treatment
work_keys_str_mv AT liuj stateoftheartinosteoporosisriskassessmentandtreatment
AT curtise stateoftheartinosteoporosisriskassessmentandtreatment
AT cooperc stateoftheartinosteoporosisriskassessmentandtreatment
AT harveyn stateoftheartinosteoporosisriskassessmentandtreatment